BOT - Anything but charting, page-5213

We know facts, rest is just 2nd year arithmetics:

1. Japan sells 12 000 scripts monthly ..in US we should do min 20 000 per month..and Japan is growing 40% YoY...
2. Insurable drug. Confirmed.
3. Price between 600 to 700usd per script.. gives us usd 160mln in Sales
4. Margins are generally very strong 65 - 75% ( Japan sells at usd 70 but still makes $$)
5. 20 to 30 Sales people, cost approx 30mln usd per.a.
6. EBITA will be around 80 to 90mln Usd

7. Product is growing at double digits ( proof Japan) ..so in short period- can have 50% more revenue..
8. Europe easly 25% immediate upside..